Navigation Links
How HIV disables the cells' call for help

The HIV virus hides out in the very immune system cells that are meant to protect the body from viral infection. But how does it prevent these cells from mounting a full-scale attack against the invader? In research published today in the Journal of Clinical Investigation, a team at the Weizmann Institute of Science has shown how a part of a protein on the virus' outer surface interferes with the cells' normal immune response. But their work may have wider implications: this molecular fragment, which has such a devastating effect in one disease, might turn out to be an effective treatment for other disorders such as rheumatoid arthritis.

In the initial stages of HIV infection, the protein coatings of the viruses fuse with the outer membranes of T cells ?immune system cells that recognize foreign invaders and alert other types of immune cell to come to the rescue. The genetic material of the virus, which is basically a strand of RNA, then forces the cell's DNA to make copies of it. Newly minted viruses created by the host DNA later break out of the cell membrane to infect other cells. Many believed that the very act of breaking into T cells and hijacking their DNA was enough to destroy the ability of these cells to call up immune support.

But Institute scientists Prof. Yechiel Shai of the Biological Chemistry Department, Prof. Irun Cohen of the Immunology Department and graduate students Francisco Quintana and Doron Gerber thought there must be more to the story. T cells identify invaders using receptors, like security antennae, on their outer walls. A virus, especially one with its own surface equipment for seeking out specific T cells, would be hard-pressed to slip past these receptors without raising the alarm. The scientists surmised that the virus must be able to actively disable some part of the immune cell's system.

They investigated a peptide fragment called FP (fusion peptide), a segment of the HIV protein gp41 found on the viral envel
'"/>

Source:American Committee for the Weizmann Institute of Science


Page: 1 2 3

Related biology news :

1. Studies reveal how plague disables immune system, and how to exploit the process to make a vaccine
2. Device traps, disables harmful bacteria
3. HIV accessory protein disables host immunity via receptor-protein intermediary
4. Two chemicals boost immune cells ability to fight HIV without gene therapy
5. Once given no respect, cells tiny RNAS take drivers seat
6. Stem cells electric abilities might help their safe clinical use
7. Scientists discover the molecular switch for nerve cells insulating jelly rolls
8. New insight into machinery of immune cells tentacles
9. Failure of scout cells may lead to cancer in transplant patients
10. Allergy cells can aggravate cancer and psoriasis
11. A key antibody, IgG, links cells capture and disposal of germs

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: How HIV disables the cells call for help

(Date:12/2/2009)... student at the University of Southampton,s School... Oceanography Centre, Southampton (NOCS) has forma...rom the deep sea. , Hall discovered the new spec... Museum of Natural History in Washington. Explaini...rabs include some of the largest crustaceans curre...
(Date:12/1/2009)...nts have two different feeding strategies. A larg...ning that they are generalist predators feeding on...s. Some, however, are "herbivorous". This is not...k of their diets consist of plant-derived matter. ... by plants to attract ants, called extra-floral ne...
(Date:12/1/2009)...ptiNose is pleased to announce the publication of ...ting the efficacy and tolerability of its novel, i...tment of chronic rhinosinusitis with nasal polyps ...ational and European Rhinologic Societies. , Ch...c disease that can significantly reduce a patient,...
Breaking Biology News(10 mins):King crab family bigger than ever 2Bacterial gut symbionts are tightly linked with the evolution of herbivory in ants 2New data on highly effective treatment for chronic rhinosinusitis with nasal polyps 2Spectral appoints new board member 13559 1Spectral appoints new board member 13559 2New Mexico School Boards Association and Accelify Announce Alliance to Assist New Mexico Schools 54497 1New Mexico School Boards Association and Accelify Announce Alliance to Assist New Mexico Schools 54497 2Dr Robert Lanza is Featured Guest on Deepak Chopras SIRIUS XM Stars Radio Show 13558 1Dr Robert Lanza is Featured Guest on Deepak Chopras SIRIUS XM Stars Radio Show 13558 2Dr Robert Lanza is Featured Guest on Deepak Chopras SIRIUS XM Stars Radio Show 13558 3
... issue of Restoration Ecology finds that in coasta...Oyster reefs are self-sustaining, and are addition... have the potential for long-term growth, and cont... , Oyster larvae move in groups and water-borne ch...re therefore able to maintain themselves as new re...
...nternational consortium of scientists, including a...e for Molecular Bioscience (IMB), will transform o...e a complex organism like a human being. , The fi...mic Sciences Center, RIKEN Yokohama Institute and ..., will be published today in two papers in the pre...
...anksgiving dinner table might consider giving than...uice, say dental researchers who have discovered t...ing cavities. , A team led by oral biologist Hyun... Rochester Medical Center has discovered that the ...eapon against bladder infections also hold promise...
Other Biology News:New insights into the software of life 2Give thanks for the cranberry, say dental researchers 2Give thanks for the cranberry, say dental researchers 3
(Date:12/2/2009)...RNewswire-FirstCall/ -- Peregrine Pharmaceuticals,...f patient enrollment in a dose confirmation and do...apsed glioblastoma multiforme (GBM), the deadliest...lonal antibody linked to a radioisotope being deve...a specifically targets cells at the center of brai...
(Date:12/2/2009)...ds, December 2 Pepscan Holding NV,...ing on protein mimicking,technology for the genera...t,has appointed Wim E.M. Mol, Ph.D. as new Chief E...nsible for all of Pepscans corporate functions and... the company. He brings to,Pepscan more than 20 ye...
(Date:12/2/2009)...ewswire/ -- S*BIO Pte Ltd today announced data pre...8, at The American Society of Hematology 51st Annu...ta will be presented on the clinical results from ...ing its safety, tolerability and pharmacokinetic/p...ing from 100 to 600 mg. These doses were administe...
(Date:12/2/2009)...ire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: A...aceutical company focused on endocrine therapy and...Drug Administration (FDA) has granted Fast Track d...bitor compound, perifosine (KRX-0401), for the tre...ryx Biopharmaceuticals, Inc. ("Keryx") ( KERX), is...
Breaking Biology Technology:Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5Dutch Biotech Company Pepscan Appoints New CEO 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3
...annKind,Corporation (Nasdaq: MNKD ) will release ..., May 5, 2008 at 4:00 p.m. EDT., Management of th...he,first quarter financial results, clinical progr...T on Monday, May 5, 2008. Presenting from the,Comp...er, Alfred Mann;,President and Chief Operating Off...
...angamo,BioSciences, Inc. (Nasdaq: SGMO ), a leade...nger DNA-binding proteins (ZFPs) for therapeutic g...he nomination of Thomas G.,Wiggans to the company,...served as Chief Executive Officer of,Connetics Cor...as Chairman,of the Board from January 2006, until ...
... prepares for commercial launch of first ...28 AssureRx, a personalized medicine,company, ann...e president,of sales and marketing. He will be res...tial launch strategy, building the sales force, an...ny,s first product. Lucas is an,experienced pharma...
Other Biology Technology:MannKind Corporation to Hold First Quarter Financial Results Conference Call on May 5, 2008 2Sangamo BioSciences Nominates Thomas G. Wiggans to Its Board of Directors 2Sangamo BioSciences Nominates Thomas G. Wiggans to Its Board of Directors 3Sangamo BioSciences Nominates Thomas G. Wiggans to Its Board of Directors 4AssureRx Adds VP of Sales and Marketing 2
SlideHyb™ Glass Array Hybridization Survey Kit from Ambion
GeneTraffic from Iobion Informatics
...a collection and automation that is controlled fro...with Microsoft Excel , Pre-configured library of ...sity meters, force gauges, spectrophotometers, etc...and configured by the user , Collect data from m...
...m binding proteins such as calmodulin and troponin...whereas S100B is composed of two beta chains. S10...ing cells such as the Langerhans cells in skin and... of lymph nodes. Epitope: Not determined Immun...
Biology Products: